These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31593512)

  • 1. Mapping the Synthetic Biology Industry: Implications for Biosecurity.
    Carter S; DiEuliis D
    Health Secur; 2019; 17(5):403-406. PubMed ID: 31593512
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in Synthetic Biology Applications, Tools, Industry, and Oversight and Their Security Implications.
    Carter SR; Warner CM
    Health Secur; 2018; 16(5):320-333. PubMed ID: 30339097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosecurity. New biosecurity rules to target the riskiest pathogens.
    Bhattacharjee Y
    Science; 2010 Jul; 329(5989):264-5. PubMed ID: 20647433
    [No Abstract]   [Full Text] [Related]  

  • 4. HHS will lead government-wide effort to enhance biosecurity.
    J Investig Med; 2004 May; 52(4):233-4. PubMed ID: 15521537
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic Biology in the Driving Seat of the Bioeconomy.
    Flores Bueso Y; Tangney M
    Trends Biotechnol; 2017 May; 35(5):373-378. PubMed ID: 28249675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HHS guidance on synthetic DNA is the right step.
    Gronvall GK
    Biosecur Bioterror; 2010 Dec; 8(4):373-6. PubMed ID: 21142764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public Health and biosecurity. The limits of government regulation of science.
    Kraemer JD; Gostin LO
    Science; 2012 Mar; 335(6072):1047-9. PubMed ID: 22267583
    [No Abstract]   [Full Text] [Related]  

  • 8. From synthetic biology to biohacking: are we prepared?
    Bennett G; Gilman N; Stavrianakis A; Rabinow P
    Nat Biotechnol; 2009 Dec; 27(12):1109-11. PubMed ID: 20010587
    [No Abstract]   [Full Text] [Related]  

  • 9. Strengthening Security for Gene Synthesis: Recommendations for Governance.
    Kobokovich A; West R; Montague M; Inglesby T; Gronvall GK
    Health Secur; 2019; 17(6):419-429. PubMed ID: 31755783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. California shows the way for biosecurity in commercial gene synthesis.
    West R; Gronvall GK
    Nat Biotechnol; 2020 Sep; 38(9):1021. PubMed ID: 32811990
    [No Abstract]   [Full Text] [Related]  

  • 11. Biosecurity. Lawmakers signal tougher controls on pathogen research.
    Bhattacharjee Y
    Science; 2009 Oct; 326(5949):28-9. PubMed ID: 19797630
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosecurity in the age of Big Data: a conversation with the FBI.
    You E; Kozminski KG
    Mol Biol Cell; 2015 Nov; 26(22):3894-7. PubMed ID: 26543195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing the hostile use of the life sciences and biotechnologies; fostering a culture of biosecurity and dual use awareness. Conclusions.
    Sture J; Whitby S
    Med Confl Surviv; 2012; 28(1):99-105. PubMed ID: 22606764
    [No Abstract]   [Full Text] [Related]  

  • 14. What rough beast?
    Mukunda G; Oye KA; Mohr SC
    Politics Life Sci; 2009 Sep; 28(2):2-26. PubMed ID: 20205520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HHS creates new advisory board to improve biosecurity in "dual use" research.
    Shalev M
    Lab Anim (NY); 2004 Apr; 33(4):14. PubMed ID: 15141252
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosecurity. New panel to offer guidance on dual-use science.
    Kaiser J
    Science; 2005 Jul; 309(5732):230. PubMed ID: 16002588
    [No Abstract]   [Full Text] [Related]  

  • 17. Defining the Synthetic Biology Supply Chain.
    Frazar SL; Hund GE; Bonheyo GT; Diggans J; Bartholomew RA; Gehrig L; Greaves M
    Health Secur; 2017; 15(4):392-400. PubMed ID: 28767286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles, property rights, and profits: historical reflections on university/industry relations.
    Kevles DJ
    Account Res; 2001; 8(4):293-307. PubMed ID: 12481797
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical and regulatory challenges posed by synthetic biology.
    Rager-Zisman B
    Perspect Biol Med; 2012; 55(4):590-607. PubMed ID: 23502567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, security, and serving the public interest in synthetic biology.
    Gronvall GK
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):463-466. PubMed ID: 29560534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.